Traditionally seen as a male disease, heart disease is now one of the leading causes of death in post-menopausal women in Europe. 心臟病過(guò)去被認為是男性的疾病，現在則是歐洲絕經(jīng)后女性的首位死因。
However, the consulting panel says, FDA needs consideration whether it is a necessity to make a genetic test before Tamoxifen is prescribed to the postmenstrual women. 不過(guò)，顧問(wèn)小組說(shuō)，醫生在為絕經(jīng)后女性開(kāi)具他莫西芬這種處方藥時(shí)，是否必須先作基因測試，仍需藥管局再作考慮。
